Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Clinical Investigation

• Publication date

  1996-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI118598PMID 8601637PMCID PMC507236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody.

  1995cited by this paper
• Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity.

  1994cited by this paper
• Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation.

  1994cited by this paper
• Constitutive NF-kappa B activity in neurons

  1994cited by this paper
• Function and activation of NF-kappa B in the immune system.

  1994influential reference
• An Evolutionary and Functional Approach to the TNF Receptor/Ligand Family

  1994cited by this paper
• Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis

  1994cited by this paper
• Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene

  1994cited by this paper
• Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals.

  1994cited by this paper
• NK-kappa B subunit-specific regulation of the I kappa B alpha promoter.

  1994cited by this paper
• Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells.

  1994cited by this paper
• Markers of mouse macrophage development detected by monoclonal antibodies.

  1994cited by this paper
• Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice.

  1994cited by this paper
• Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes.

  1994cited by this paper
• Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993influential reference
• Role of oxidised low density lipoprotein in atherogenesis.

  1993influential reference
• Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.

  1993cited by this paper
• Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.

  1993cited by this paper
• Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.

  1993cited by this paper
• NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

  1993influential reference
• Coronary atherosclerosis : a multifactorial disease

  1993cited by this paper
• Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells.

  1993cited by this paper
• Nuclear factor kappa B, a mediator of lipopolysaccharide effects.

  1993cited by this paper
• Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).

  1992cited by this paper
• Functional analysis of the human vascular cell adhesion molecule 1 promoter

  1992cited by this paper
• Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.

  1992cited by this paper
• Expression of intercellular adhesion molecule-1 in atherosclerotic plaques.

  1992influential reference
• Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.

  1992cited by this paper
• A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis.

  1992cited by this paper
• Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

  1991cited by this paper
• The Structural Biology of Expression and Function of Tissue Factor

  1991cited by this paper
• Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.

  1991cited by this paper
• Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide

  1991cited by this paper
• Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

  1991cited by this paper
• Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites

  1991cited by this paper
• Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein.

  1991cited by this paper
• Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis.

  1991cited by this paper
• Role of oxidized low density lipoprotein in atherogenesis.

  1991cited by this paper
• The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.

  1991cited by this paper
• Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization.

  1990cited by this paper
• Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation.

  1990cited by this paper
• Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque.

  1990cited by this paper
• Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages.

  1990cited by this paper
• Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.

  1990cited by this paper
• Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

  1990cited by this paper
• NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

  1989cited by this paper
• Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy.

  1989cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

  1988cited by this paper
• Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions.

  1986cited by this paper
• A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride.

  1986influential reference

• Circadian Immunity and Vascular Inflammation in Cardiovascular Disease Chronotherapy Windows: Time for a Re‐Assessment

  2026cites this paper
• Sparstolonin B and Curcumin alleviate atherogenesis by modulating T helper 17-stromal cell interactions associated with interleukin-17 receptor A (IL-17RA) - transforming growth factor-β-activated kinase 1 (TAK1) - nuclear factor-kappa B (NF-κB) signaling.

  2025cites this paper
• The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities

  2025cites this paper
• NF-κB in inflammation and cancer

  2025cites this paper
• Studies on some antiatherosclerotic medicinal plants of Bangladesh

  2025cites this paper
• AEBP1 or ACLP, which is the key factor in inflammation and fibrosis?

  2025cites this paper
• Regulation of IL-6-induced NF-κB signaling by dietary plant polyphenol pinoresinol attenuates inflammation and atherogenesis in monocyte-macrophage system

  2025cites this paper
• Butyrate Produced by Gut Microbiota Regulates Atherosclerosis: A Narrative Review of the Latest Findings

  2025cites this paper
• Lipid overload meets S-palmitoylation: a metabolic signalling nexus driving cardiovascular and heart disease

  2025cites this paper
• Unraveling the RKIP–YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders

  2025cites this paper
• Defective vascular smooth muscle cell tafazzin impairs mitochondrial function and promotes atherosclerosis in preclinical models

  2025cites this paper
• Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms–a comprehensive review

  2025cites this paper
• The Role of Lysyl Oxidase in the Pathological Stage of Atherosclerosis: Structural Stabilizer or Disease Driver?

  2025cites this paper
• New Roles of Artemisinins in Atherosclerosis Progression

  2025cites this paper
• Qingre Huoxue Decoction Alleviates Atherosclerosis by Regulating Macrophage Polarization Through Exosomal miR-26a-5p

  2024cites this paper
• Adaptive immunity and atherosclerosis: aging at its crossroads.

  2024cites this paper
• The novel vaccines targeting interleukin-1 receptor type I.

  2024cites this paper
• Bioinformatics and machine learning approaches reveal key genes and underlying molecular mechanisms of atherosclerosis: A review

  2024cites this paper
• Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKKα/IκB-α/NF-κB activation.

  2024cites this paper
• Navigating the Landscape of Coronary Microvascular Research: Trends, Triumphs, and Challenges Ahead

  2024cites this paper
• Huxin Formula Inhibits Oxidized low-Density Lipoprotein-Induced Foam Cell Formation in THP-1 Macrophages via the LOX-1/NF-κB Pathway

  2024cites this paper
• A 96-wells fluidic system for high-throughput screenings under laminar high wall shear stress conditions

  2023cites this paper
• Effects and Potential Mechanism of Zhuyu Pill Against Atherosclerosis: Network Pharmacology and Experimental Validation

  2023cites this paper
• The Role of Macrophages in Cardiac Function and Disease

  2023cites this paper
• The Role and Mechanism of Metformin in Inflammatory Diseases

  2023cites this paper
• A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine

  2023cites this paper
• Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease

  2023cites this paper
• KPNA2 Silencing, Regulated by E3 Ubiquitin Ligase FBXW7, Alleviates Endothelial Dysfunction and Inflammation Through Inhibiting the Nuclear Translocation of p65 and IRF3: A Possible Therapeutic Approach for Atherosclerosis

  2023cites this paper
• Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ

  2023cites this paper
• Clotrimazole reverses macrophage M2 polarization by disrupting the PI3K/AKT/mTOR pathway.

  2023cites this paper
• EFEKTIVITAS TEH DAUN KELOR PADA HEWAN COBA TIKUS PUTIH JANTAN UNTUK MENURUNKAN KADAR KOLESTEROL

  2022cites this paper
• Kv1.3 Channel Is Involved In Ox-LDL-induced Macrophage Inflammation Via ERK/NF-κB signaling pathway.

  2022cites this paper
• Identifying Hub Genes and Immune Cell Infiltration for the Progression of Carotid Atherosclerotic Plaques in the Context of Predictive and Preventive Using Integrative Bioinformatics Approaches and Machine-Learning Strategies

  2022cites this paper
• MiR-7-5p attenuates vascular smooth muscle cell migration and intimal hyperplasia after vascular injury by NF-kB signaling

  2022cites this paper
• Immune system and atherosclerosis: Hostile or friendly relationship

  2022cites this paper
• ICAM-1-related noncoding RNA accelerates atherosclerosis by amplifying NF-κB signaling.

  2022cites this paper
• The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-κB pathway.

  2022cites this paper
• Anti-Inflammatory Effects of Heliangin from Jerusalem Artichoke (Helianthus tuberosus) Leaves Might Prevent Atherosclerosis

  2022cites this paper
• Tomatoes: An Extensive Review of the Associated Health Impacts of Tomatoes and Factors That Can Affect Their Cultivation

  2022cites this paper
• Perfluorooctane sulfonate promotes atherosclerosis by modulating M1 polarization of macrophages through the NF-κB pathway.

  2022cites this paper
• Intersection of the Ubiquitin–Proteasome System with Oxidative Stress in Cardiovascular Disease

  2022cites this paper
• NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases

  2022cites this paper
• The future Landscape of macrophage research in cardiovascular disease: a bibliometric analysis.

  2022cites this paper
• Anti-inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials.

  2021cites this paper
• Screening of Hub Genes Associated with Pulmonary Arterial Hypertension by Integrated Bioinformatic Analysis

  2021cites this paper
• HIV Protein Tat Induces Macrophage Dysfunction and Atherosclerosis Development in Low-Density Lipoprotein Receptor-Deficient Mice

  2021cites this paper
• The impact of reactive oxygen species in the development of cardiometabolic disorders: a review

  2021cites this paper
• Erythorbyl laurate suppresses TNF-α-induced adhesion of monocytes to the vascular endothelium

  2021cites this paper
• Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo.

  2021cites this paper
• Innovative nanotools for vascular drug delivery: the atherosclerosis case study.

  2021cites this paper
• Mechanosensitive molecular interactions in atherogenic regions of the arteries: development of atherosclerosis

  2021cites this paper
• Natural Compound Resveratrol Attenuates TNF-Alpha-Induced Vascular Dysfunction in Mice and Human Endothelial Cells: The Involvement of the NF-κB Signaling Pathway

  2021cites this paper
• The Transcription Factor NF-κB in Stem Cells and Development

  2021cites this paper
• Microvesicle signaling in cardiovascular biology under normal and pathobiological conditions

  2021cites this paper
• Recent Advances in Understanding the Role of IKKβ in Cardiometabolic Diseases

  2021cites this paper
• Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

  2020cites this paper
• Atherosclerosis and Inflammatory Bowel Disease—Shared Pathogenesis and Implications for Treatment

  2020cites this paper
• The Effects of Pro-Inflammatory and Anti-Inflammatory Agents for the Suppression of Intimal Hyperplasia: An Evidence-Based Review

  2020cites this paper
• MicroRNA-520c-3p targeting of RelA/p65 suppresses atherosclerotic plaque formation.

  2020cites this paper
• Downregulation of G3BP2 reduces atherosclerotic lesions in ApoE-/- mice.

  2020cites this paper
• EX VIVO IKKβ ABLATION RESCUES THE IMMUNOPOTENCY OF MESENCHYMAL STROMAL CELLS FROM DIABETICS WITH ADVANCED ATHEROSCLEROSIS.

  2020cites this paper
• Heat Shock Protein 27 Immune Complex Altered Signaling and Transport (ICAST): Novel Mechanisms of Attenuating Inflammation

  2020cites this paper
• Prevention of Endothelial Dysfunction and Cardiovascular Disease by n-3 Fatty Acids-Inhibiting Action on Oxidative Stress and Inflammation.

  2020cites this paper
• Ficus deltoidea suppresses endothelial activation, inflammation, monocytes adhesion and oxidative stress via NF-κB and eNOS pathways in stimulated human coronary artery endothelial cells

  2020cites this paper
• Atherosclerotic Cardiovascular Disease

  2020cites this paper
• RIPK1 Expression Associates with Inflammation in Early Atherosclerosis in Humans and Can be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice.

  2020cites this paper
• Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges

  2020cites this paper
• The expression and significance of NF-κB, MMP1, and MMP2 in rats with abdominal aortic aneurysm.

  2020cites this paper
• Molecular Signature of the Immune Response to Yoga Therapy in Stress-related Chronic Disease Conditions: An Insight

  2020cites this paper
• Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis.

  2020cites this paper
• Immunosenescence, Oxidative Stress, and Cancers

  2020cites this paper
• Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-κB.

  2020cites this paper
• Effect of Sudharshan Kriya Pranayama on Salivary Expression of Human Beta Defensin-2, Peroxisome Proliferator-Activated Receptor Gamma, and Nuclear Factor-Kappa B in Chronic Periodontitis

  2020cites this paper
• Intermittent Hypoxia and Hypercapnia Induces Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta-dependent Atherosclerosis in Pulmonary Arteries.

  2019cites this paper
• [Role of PPARγ, a transcription factor in cardiovascular disease].

  2019cites this paper
• Effect of iPSCs-derived keratinocytes on healing of full-thickness skin wounds in mice.

  2019cites this paper
• Intermittent hypoxia and hypercapnia induces inhibitor of nuclear factor- (cid:2) B kinase subunit (cid:3) -dependent atherosclerosis in pulmonary arteries

  2019cites this paper
• Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques.

  2019cites this paper
• Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE-/- mice.

  2019cites this paper
• Etlingera pavieana extract attenuates TNF-α induced vascular adhesion molecule expression in human endothelial cells through NF-κB and Akt/JNK pathways

  2019cites this paper
• Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases

  2019cites this paper
• Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice

  2019cites this paper
• NF-κB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase

  2019cites this paper
• The Role of Monocytes and Macrophages in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis

  2019cites this paper
• Cholesterol crystals promote endothelial cell and monocyte interactions via H2O2-mediated PP2A inhibition, NFκB activation and ICAM1 and VCAM1 expression

  2019cites this paper
• Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells

  2019cites this paper
• Lack of IκBNS promotes cholate-containing high-fat diet-induced inflammation and atherogenesis in low-density lipoprotein (LDL) receptor-deficient mice

  2019cites this paper
• Angiotensin II Increases Endoplasmic Reticulum Stress in Adipose Tissue and Adipocytes

  2019cites this paper
• Effect of nebivolol on altered skeletal and cardiac muscles induced by dyslipidemia in rats: impact on oxidative and inflammatory machineries

  2019cites this paper
• Shear-Induced CCN1 Promotes Atheroprone Endothelial Phenotypes and Atherosclerosis.

  2019cites this paper
• Carbon Nanodot Cellular Uptake and Modulation of Tumor Necrosis Factor-Alpha-Induced Endothelial Dysfunction

  2018cites this paper
• Metformin ameliorates the progression of atherosclerosis via suppressing macrophage infiltration and inflammatory responses in rabbits

  2018cites this paper
• Nitric Oxide-Delivering High-Density Lipoprotein-like Nanoparticles as a Biomimetic Nanotherapy for Vascular Diseases.

  2018cites this paper
• Mechanism of LPA ‐ induced lipid uptake in macrophages

  2018cites this paper
• In vitro cell models of vascular calcification: integrative roles for RANKL and TRAIL

  2018cites this paper
• Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways.

  2018cites this paper
• M2b macrophage polarization and its roles in diseases

  2018cites this paper
• Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions.

  2018cites this paper
• Insights on Localized and Systemic Delivery of Redox-Based Therapeutics

  2018cites this paper
• Fibroblast growth factor 21 regulates foam cells formation and inflammatory response in Ox-LDL-induced THP-1 macrophages.

  2018cites this paper